Paysign Resultados de beneficios anteriores

Pasado controles de criterios 6/6

Paysign ha aumentado sus beneficios a una tasa media anual de 20.1%, mientras que los beneficios de la industria de Diversified Financial han experimentado un crecimiento de 11.1% anual. Los ingresos han ido creciendo a una tasa media de 13.6% al año. La rentabilidad financiera de Paysign es de 28.3%, y sus márgenes netos son de 14.3%.

Información clave

20.1%

Tasa de crecimiento de los beneficios

17.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Diversified Financial	6.1%
Tasa de crecimiento de los ingresos	13.6%
Rentabilidad financiera	28.3%
Margen neto	14.3%
Última actualización de beneficios	30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

Desglose de ingresos y gastos

Cómo gana y gasta dinero Paysign. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqCM:PAYS Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Sep 24	56	8	24
30 Jun 24	54	8	22
31 Mar 24	50	7	22
31 Dec 23	47	6	21
30 Sep 23	44	2	20
30 Jun 23	42	1	20
31 Mar 23	40	1	18
31 Dec 22	38	1	18
30 Sep 22	36	0	18
30 Jun 22	33	-1	17
31 Mar 22	31	-1	17
31 Dec 21	29	-3	16
30 Sep 21	28	-7	15
30 Jun 21	20	-13	15
31 Mar 21	20	-12	15
31 Dec 20	24	-9	15
30 Sep 20	27	-3	14
30 Jun 20	36	6	13
31 Mar 20	38	8	13
31 Dec 19	35	7	12
30 Sep 19	32	6	11
30 Jun 19	29	4	10
31 Mar 19	26	3	9
31 Dec 18	23	3	8
30 Sep 18	21	2	6
30 Jun 18	19	2	6
31 Mar 18	17	2	5
31 Dec 17	15	2	4
30 Sep 17	14	2	3
30 Jun 17	12	2	3
31 Mar 17	11	2	3
31 Dec 16	10	1	3
30 Sep 16	10	1	3
30 Jun 16	9	-2	3
31 Mar 16	9	-2	4
31 Dec 15	8	-2	4
30 Sep 15	11	0	4
30 Jun 15	11	3	3
31 Mar 15	9	2	3
31 Dec 14	10	3	3
30 Sep 14	7	0	2
30 Jun 14	7	0	2
31 Mar 14	7	0	2
31 Dec 13	6	1	1

Ingresos de calidad: PAYS tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (14.3%) de PAYS son superiores a los del año pasado (3.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lPAYS han crecido significativamente en un 20.1% al año.

Acelerando crecimiento: El crecimiento de los beneficios de PAYS en el último año (420.5%) supera su media de 5 años (20.1% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de PAYS en el último año (420.5%) superó al de la industria Diversified Financial 14.5%.

Paysign Resultados de beneficios anteriores

Pasado controles de criterios 6/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022